Perceptive Advisors »

Aeglea Biotherapeutics shares owned by Perceptive Advisors

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Perceptive Advisors from 13F filings

Historical chart of Perceptive Advisors investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by Perceptive Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by Perceptive Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $56M 2.6M 21.52
2023-09-30 $994k 81k 12.25